Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$4,126,644
+$465,200 QoQ
Shares Held
16,399
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,434
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Resonant Capital Advisors, LLC holds $36,919,957 across 13 Drug Manufacturers - General names. ABBV ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,392 | $7,666,757 | |
| 2 | AMGN |
Amgen Inc
|
15,803 | $5,722,582 | |
| 3 | JNJ |
Johnson & Johnson
|
19,135 | $4,859,715 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
16,399 | $4,126,644 | |
| 5 | MRK |
Merck & Co., Inc.
|
31,697 | $4,073,064 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
30,095 | $3,802,202 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
49,118 | $2,830,179 | |
| 8 | PFE |
Pfizer Inc
|
52,773 | $1,270,773 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,126,644 | 16,399 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $3,661,444 | 16,835 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $3,508,463 | 15,355 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,611,097 | 15,596 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,885,648 | 15,546 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $3,045,792 | 14,537 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,556,569 | 14,387 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,865,039 | 14,508 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,328,727 | 13,577 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,412,825 | 13,250 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,925,812 | 12,427 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,844,766 | 12,376 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $1,666,879 | 12,372 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,019,536 | 12,672 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $2,057,618 | 12,732 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $1,608,238 | 11,983 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $1,782,016 | 11,635 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $1,816,604 | 11,206 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,469,902 | 10,856 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,086,898 | 10,076 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $1,040,117 | 9,234 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $997,896 | 9,221 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $847,663 | 7,911 | Shares | Sole | 2021-01-15 | |
| 2020-09-30 | $720,252 | 8,223 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $871,445 | 8,876 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $668,338 | 8,772 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||